P

Protalix Biotherapeutics Inc
AMEX:PLX

Watchlist Manager
Protalix Biotherapeutics Inc
AMEX:PLX
Watchlist
Price: 1.79 USD 3.47% Market Closed
Market Cap: 144m USD

Wall Street
Price Targets

PLX Price Targets Summary
Protalix Biotherapeutics Inc

There are no price targets for PLX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Protalix Biotherapeutics Inc Competitors:
Price Targets
GOSS
Gossamer Bio Inc
155% Upside
ALEC
Alector Inc
44% Upside
VYGR
Voyager Therapeutics Inc
263% Upside
CYTK
Cytokinetics Inc
27% Upside
1801
Innovent Biologics Inc
31% Upside
XNCR
Xencor Inc
80% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
SYNACT
SynAct Pharma AB
20% Upside

Revenue
Forecast

Revenue Estimate
Protalix Biotherapeutics Inc

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 10%.

25%
Past Growth
10%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Protalix Biotherapeutics Inc

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 59%.

N/A
Past Growth
59%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Protalix Biotherapeutics Inc

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 74%.

N/A
Past Growth
74%
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PLX's stock price target?
Not Available

PLX doesn't have any price targets made by Wall Street professionals.

What is Protalix Biotherapeutics Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 10%.

What is Protalix Biotherapeutics Inc's Operating Income forecast?
Projected CAGR
59%

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 59%.

What is Protalix Biotherapeutics Inc's Net Income forecast?
Projected CAGR
74%

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 74%.

Back to Top